Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

NCT05900895 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Olaparib
DRUG: 17b-estradiol

Sponsor

Mary D Chamberlin

Collaborators

[object Object]